Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

EKVAPRESS™ modified-release capsules 10mg+1.5mg+20mg, 28pcs

🔥 10 items sold in last 3 hours
18 people are viewing this product
Brand:
Active Ingredient:

, ,

Manufacturer:

$82.5

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

OLEOS SUPERCHISTOTEL™ solution 5ml, 1pc

$15.0
Add to cart

ABAKTAL™ tablets 400mg, 10pcs

$56.0
Add to cart

Analogs of EKVAPRESS™

AMLODIPINE+VALSARTAN tablets 5mg+80mg, 90pcs

$59.0
Add to cart

AMLODIPINE tablets 10mg, 120pcs

$20.0
Add to cart

AMLODIPINE tablets 10mg, 30pcs

$9.5
Add to cart

AMLODIPINE tablets 10mg, 60pcs

$17.5
Add to cart

Table of Contents

EKVAPRESS™ 10mg+1.5mg+20mg Capsules Buy Online

EKVAPRESS Modified-Release Capsules: A Comprehensive Overview

Managing high blood pressure effectively requires a multifaceted approach. EKVAPRESS modified-release capsules offer a convenient, combined therapy option for patients needing comprehensive blood pressure control.

This medication combines three key active ingredients: amlodipine, indapamide, and lisinopril. These components work synergistically to address various aspects of hypertension, offering a potentially superior outcome compared to single-agent therapies.

The modified-release formulation ensures a sustained and controlled release of the active ingredients, leading to a more consistent reduction in blood pressure throughout the day. This minimizes the fluctuations often seen with immediate-release medications.

EKVAPRESS is designed for patients whose blood pressure remains uncontrolled despite treatment with individual components. The combination therapy simplifies medication regimens and may improve adherence.

Understanding EKVAPRESS

EKVAPRESS is a fixed-dose combination medication designed to manage high blood pressure (hypertension). It’s not a single-agent drug but a carefully formulated blend of three distinct antihypertensive components, each contributing to its overall effectiveness. This triple-action approach is intended for patients requiring a more comprehensive approach to blood pressure control.

The synergistic action of these ingredients offers advantages over monotherapy. By combining amlodipine (a calcium channel blocker), indapamide (a thiazide-like diuretic), and lisinopril (an ACE inhibitor), EKVAPRESS targets multiple pathways involved in regulating blood pressure. This multifaceted approach may lead to more effective blood pressure management than using any single drug alone.

Amlodipine helps relax blood vessels, reducing resistance to blood flow. Indapamide promotes fluid excretion, reducing blood volume. Lisinopril inhibits the production of substances that narrow blood vessels. The combined effect of these mechanisms lowers blood pressure more effectively and sustainably for many patients.

The modified-release formulation is a crucial aspect of EKVAPRESS. This design ensures a gradual and consistent release of the active ingredients throughout the day. This controlled release minimizes fluctuations in blood pressure levels, promoting smoother and more stable control compared to immediate-release formulations. This feature is vital for maintaining consistent therapeutic effects over an extended period.

Understanding the individual roles and combined effects of these active components is key to appreciating the comprehensive approach EKVAPRESS offers in managing hypertension. The modified-release aspect further enhances its effectiveness and tolerability for many individuals needing effective and stable blood pressure control.

Mechanism of Action

EKVAPRESS’s effectiveness stems from the combined actions of its three active ingredients, each targeting different aspects of blood pressure regulation. This synergistic approach offers a more comprehensive and potentially more effective blood pressure control than single-agent therapies.

Amlodipine, a calcium channel blocker, works by relaxing the blood vessels, reducing the resistance to blood flow (peripheral vascular resistance). This vasodilation leads to a decrease in blood pressure. The effect is a widening of the arteries, making it easier for blood to pass through.

Indapamide, a thiazide-like diuretic, increases the excretion of sodium and water from the body. This reduction in blood volume contributes significantly to lowering blood pressure. The decrease in fluid volume lessens the strain on the cardiovascular system.

Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, works by blocking the production of angiotensin II, a potent vasoconstrictor. By inhibiting angiotensin II, lisinopril prevents the narrowing of blood vessels, further reducing peripheral vascular resistance and contributing to lower blood pressure. This action also has beneficial effects on the heart itself.

The combined effects of these three mechanisms—vasodilation, reduced blood volume, and inhibition of vasoconstriction—result in a significant and sustained reduction in blood pressure. The modified-release formulation ensures a consistent and prolonged effect, minimizing blood pressure fluctuations throughout the day.

It is important to note that the precise contribution of each component may vary among individuals, reflecting the complexity of blood pressure regulation. This combined approach allows for a more personalized and effective management of hypertension for a broader spectrum of patients.

Therapeutic Benefits

EKVAPRESS offers several key therapeutic benefits, primarily focused on the management and control of hypertension. Its multi-component approach provides a more comprehensive strategy than single-agent therapies, potentially leading to superior outcomes for many patients.

The primary benefit is the reduction of blood pressure. By targeting multiple physiological pathways involved in blood pressure regulation, EKVAPRESS achieves a more substantial and sustained decrease in both systolic and diastolic blood pressure compared to monotherapy in many cases. This reduction is crucial in preventing the long-term complications associated with uncontrolled hypertension.

Beyond blood pressure reduction, EKVAPRESS may offer additional therapeutic advantages. The included ACE inhibitor (lisinopril) possesses cardioprotective properties, helping to protect the heart from damage associated with high blood pressure. This protective effect is particularly important in reducing the risk of heart attacks, strokes, and other cardiovascular events.

Furthermore, the combination therapy may improve patient compliance. A single pill containing multiple agents simplifies the medication regimen, potentially improving adherence to the prescribed treatment. Consistent medication use is crucial for successful long-term blood pressure management.

In summary, the therapeutic advantages of EKVAPRESS extend beyond simply lowering blood pressure. It offers cardioprotection, simplifies treatment regimens, and potentially enhances overall patient outcomes through its multi-faceted approach to managing hypertension. The sustained-release formulation contributes to the consistency of therapeutic benefits.

It’s crucial to remember that individual responses to medication can vary. Consultation with a healthcare professional is essential for personalized treatment plans and monitoring of therapeutic effects. The benefits listed here represent the potential advantages, not a guaranteed outcome for all users.

Potential Side Effects

While EKVAPRESS offers significant therapeutic benefits, it’s crucial to be aware of potential side effects. These side effects are not experienced by everyone, and their severity can vary greatly among individuals. The frequency and intensity of side effects are also influenced by factors such as dosage and individual patient characteristics.

Some common side effects associated with the individual components of EKVAPRESS include headache, dizziness, fatigue, and nausea. These are often mild and transient, resolving spontaneously or with simple management strategies. However, if these or any other side effects persist or worsen, medical attention should be sought.

More serious, though less common, side effects can include cough, swelling in the ankles or feet (edema), and changes in blood potassium levels. These require careful monitoring and, in some instances, may necessitate adjustments to the medication regimen or discontinuation of the therapy. Regular checkups with a healthcare provider are essential for managing potential complications.

Rare but potentially severe side effects, such as angioedema (severe swelling of the face, lips, tongue, or throat), can occur. This is a medical emergency requiring immediate medical attention. Patients should be educated about the signs and symptoms of angioedema to ensure prompt recognition and treatment.

This information is not exhaustive and does not replace the need for comprehensive consultation with a healthcare professional. A thorough discussion of potential risks and benefits, alongside individual patient factors, is crucial before initiating treatment with EKVAPRESS. Always report any new or worsening symptoms to your doctor.

Patients with pre-existing conditions, such as kidney or liver disease, should discuss potential risks with their physicians before starting EKVAPRESS. This detailed discussion will help determine the suitability of the medication and help mitigate any potential adverse effects.

Pros

EKVAPRESS offers several key advantages in the management of hypertension, making it a potentially valuable treatment option for many patients. Its multi-component formulation and modified-release design contribute significantly to its benefits.

  • Effective Blood Pressure Control: The combination of amlodipine, indapamide, and lisinopril provides a multifaceted approach to lowering blood pressure, often leading to better control than single-agent therapies. This comprehensive approach addresses multiple factors contributing to hypertension.
  • Simplified Regimen: A single daily dose simplifies medication adherence, a crucial factor in long-term hypertension management. This convenience can improve patient compliance, leading to better overall outcomes.
  • Sustained-Release Formulation: The modified-release design ensures a consistent release of active ingredients, minimizing blood pressure fluctuations throughout the day. This consistent control is often more comfortable and effective than immediate-release formulations.
  • Potential Cardioprotective Effects: The inclusion of lisinopril, an ACE inhibitor, provides potential cardioprotective benefits, reducing the risk of cardiovascular events associated with hypertension. This added protection is a significant advantage for many patients.
  • Improved Patient Outcomes: The combination of effective blood pressure control, simplified regimen, and cardioprotection can significantly improve patient outcomes and quality of life. This holistic approach addresses the multifaceted nature of hypertension.

It is important to remember that individual responses to medication vary. While these are significant potential benefits, the actual experience may differ among patients. A healthcare professional can provide personalized guidance and monitor the effectiveness of the treatment.

Cons

While EKVAPRESS offers many benefits, potential drawbacks should be considered. These potential downsides are not universal and their impact varies significantly between individuals. Careful consideration of these factors is crucial before initiating treatment.

  • Side Effects: Like all medications, EKVAPRESS can cause side effects. These range from mild (headache, dizziness, nausea) to more serious (cough, swelling, changes in potassium levels, angioedema). The risk of specific side effects depends on individual factors and pre-existing conditions. Regular monitoring is necessary to detect and manage any adverse reactions.
  • Drug Interactions: EKVAPRESS may interact with other medications, potentially altering their effectiveness or increasing the risk of side effects. A comprehensive review of all medications and supplements is essential before starting treatment. This interaction risk is common with many medications and requires careful management.
  • Contraindications: Certain medical conditions may make EKVAPRESS unsuitable. Pre-existing kidney or liver disease, certain heart conditions, or allergies to the active ingredients are examples of contraindications. A thorough medical history and assessment are crucial before prescription.
  • Individual Response Variability: The effectiveness of EKVAPRESS can vary significantly between patients. What works well for one person may not be as effective for another. Regular monitoring of blood pressure and other health indicators is vital to assess treatment efficacy.
  • Monitoring Requirements: Regular blood tests may be necessary to monitor kidney function and potassium levels, particularly in high-risk patients. This monitoring helps ensure the safe and effective use of the medication and prevents potential complications.

It’s vital to discuss potential risks and benefits with a healthcare provider before starting EKVAPRESS. This personalized assessment will help determine the suitability of the medication and facilitate effective management of any potential adverse effects. Open communication with your physician is key to a successful treatment plan.

Important Considerations

Before starting EKVAPRESS, several crucial factors require careful consideration to ensure safe and effective treatment. These considerations are essential for optimizing therapeutic outcomes and minimizing potential risks.

Pre-existing Conditions: Patients with kidney or liver disease, heart problems (such as heart failure or aortic stenosis), or a history of angioedema should discuss these conditions with their doctor before starting EKVAPRESS. These conditions can influence treatment suitability and necessitate close monitoring.

Drug Interactions: EKVAPRESS can interact with other medications, including diuretics, potassium supplements, and certain pain relievers. A complete list of all medications, supplements, and herbal remedies currently being taken should be provided to the healthcare professional. This information is crucial for identifying potential drug interactions and preventing adverse effects.

Pregnancy and Breastfeeding: EKVAPRESS is generally not recommended during pregnancy or breastfeeding. The potential risks to the fetus or infant outweigh the benefits of the medication in most cases. Alternative treatment options should be explored during these periods.

Monitoring: Regular monitoring of blood pressure, kidney function, and potassium levels is often recommended, especially during the initial phase of treatment and for patients with pre-existing conditions. This proactive monitoring allows for early detection of any adverse effects or inefficacy of the treatment.

Lifestyle Modifications: EKVAPRESS is most effective when combined with lifestyle modifications such as a healthy diet, regular exercise, and stress management techniques. These changes can significantly enhance the medication’s effectiveness and contribute to overall cardiovascular health. A holistic approach to managing hypertension is generally more effective.

Open communication with your healthcare provider is paramount throughout the treatment process. Any concerns or questions regarding EKVAPRESS should be addressed promptly to ensure safe and effective management of hypertension.

Dosage and Administration

The appropriate dosage and administration of EKVAPRESS should always be determined by a healthcare professional. Self-adjusting the dosage can be dangerous and should never be attempted. Dosage is highly individualized based on patient response and other health factors.

Typically, EKVAPRESS is administered once daily, usually in the morning. The medication should be swallowed whole with a glass of water; crushing or chewing the capsules is not recommended as this can alter the controlled-release properties of the medication. Consistent timing of administration is also important to maintain consistent therapeutic levels of the active ingredients.

The starting dose may be lower than the standard dose, particularly for patients with pre-existing conditions or those at higher risk for side effects. The doctor may gradually increase the dosage over time to achieve optimal blood pressure control, closely monitoring the patient’s response and tolerance to the medication. This titration approach allows for personalized treatment.

It’s crucial to follow the prescribed dosage and administration instructions precisely. Missing doses or altering the prescribed regimen can affect the medication’s effectiveness and may lead to increased blood pressure fluctuations. Any questions or concerns regarding dosage or administration should be clarified with a healthcare professional.

If a dose is missed, it should be taken as soon as possible, unless it’s almost time for the next dose. In such cases, simply skip the missed dose and continue with the regular dosing schedule. Never double up on doses to compensate for a missed one. Consistent adherence to the prescribed schedule is paramount for effective blood pressure control.

Patients should inform their doctors of any adverse effects they experience. Adjustments to the dose or alternative treatment options may be necessary if side effects become intolerable or if the medication is not effectively controlling blood pressure. Regular monitoring and communication are essential for safe and effective treatment.

  • Ekvapress™ Modified-Release Capsules 10Mg+1.5Mg+20Mg, 28Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Ekvapress™ Modified-Release Capsules 10Mg+1.5Mg+20Mg, 28Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Ekvapress™ Modified-Release Capsules 10Mg+1.5Mg+20Mg, 28Pcs Buy Online 6
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “EKVAPRESS™ modified-release capsules 10mg+1.5mg+20mg, 28pcs”

Your email address will not be published. Required fields are marked

Similar products

APROVASK™ tablets 10mg+150mg, 28pcs

$73.5
Add to cart

APROVASK™ tablets 10mg+300mg, 28pcs

$102.5
Add to cart

APROVASK™ tablets 10mg+300mg, 56pcs

$176.0
Add to cart

ANGIAKAND™ tablets 16mg, 28pcs

$57.5
Add to cart

ANAPRILIN™ RENEVAL™ tablets 10mg, 112pcs

$9.5
Add to cart

ANAPRILIN™ tablets 10mg, 50pcs

$7.0
Add to cart

AMPRILAN™ tablets 10mg, 30pcs

$17.5
Add to cart

AMPRILAN™ tablets 10mg, 90pcs

$47.0
Add to cart

AMPRILAN™ tablets 5mg, 90pcs

$27.0
Add to cart

AMLODIPINE-TEVA™ tablets 5mg, 30pcs

$16.0
Add to cart

AMLOTOP™ tablets 10mg, 30pcs

$17.5
Add to cart

AMLODIPINE+LISINOPRIL tablets 10mg+20mg, 30pcs

$39.0
Add to cart

AMLODIPINE+PERINDOPRIL-SZ™ tablets 5mg+4mg, 30pcs

$24.0
Add to cart

AMLODIPINE-AKOS™ tablets 10mg, 30pcs

$13.5
Add to cart

AMLODIPINE-VERTEX™ tablets 10mg, 30pcs

$9.5
Add to cart

AMLODIPINE tablets 10mg, 30pcs

$9.5
Add to cart

AMLODIPINE tablets 10mg, 90pcs

$21.5
Add to cart

AMLODIPINE tablets 5mg, 90pcs

$15.0
Add to cart

AMLODIPINE tablets 5mg, 90pcs

$13.5
Add to cart

AMLODIPINE+VALSARTAN tablets 10mg+160mg, 30pcs

$40.0
Add to cart

AMLODIPINE+VALSARTAN tablets 10mg+160mg, 90pcs

$73.5
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+160mg, 30pcs

$31.0
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+80mg, 90pcs

$59.0
Add to cart

ALBAREL™ tablets 1mg, 30pcs

$84.0
Add to cart
Select your currency